ATC Group: H03BA02 Propylthiouracil

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of H03BA02 in the ATC hierarchy

Level Code Title
1 H Systemic hormonal preparations, excl. Sex hormones and insulins
2 H03 Thyroid therapy
3 H03B Antithyroid preparations
4 H03BA Thiouracils
5 H03BA02 Propylthiouracil

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 0.1 g

Active ingredients in H03BA02

Active Ingredient Description
Propylthiouracil

Propylthiouracil is an antithyroid drug that depresses the formation of thyroid hormone. This is effected by interference both with the incorporation of iodine into tyrosyl residues and the coupling of such residues to form iodothyronines. Propylthiouracil achieves these actions by the inhibition of the enzyme peroxidase.

Medicines in this ATC group

Austria (AT)

Brazil (BR)

Cyprus (CY)

Estonia (EE)

France (FR)

Hong Kong (HK)

Japan (JP)

Malta (MT)

Poland (PL)

Singapore (SG)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.